Dynamic group testing to control and monitor disease progression in a population
Sundara Rajan Srinivasavaradhan, Pavlos Nikolopoulos, Christina, Fragouli, Suhas Diggavi

TL;DR
This paper introduces a discrete-time SIR stochastic block model incorporating group testing and interventions, demonstrating that community-aware nonadaptive testing can identify all infections efficiently with significantly fewer tests.
Contribution
It develops a novel discrete-time SIR stochastic block model that integrates group testing and interventions, enabling order-optimal infection detection with fewer tests.
Findings
Order-optimal nonadaptive group testing algorithms achieved.
Fewer tests needed compared to complete testing.
Model captures community structure and time dynamics.
Abstract
In the context of a pandemic like COVID-19, and until most people are vaccinated, proactive testing and interventions have been proved to be the only means to contain the disease spread. Recent academic work has offered significant evidence in this regard, but a critical question is still open: Can we accurately identify all new infections that happen every day, without this being forbiddingly expensive, i.e., using only a fraction of the tests needed to test everyone everyday (complete testing)? Group testing offers a powerful toolset for minimizing the number of tests, but it does not account for the time dynamics behind the infections. Moreover, it typically assumes that people are infected independently, while infections are governed by community spread. Epidemiology, on the other hand, does explore time dynamics and community correlations through the well-established…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 detection and testing · COVID-19 epidemiological studies · Respiratory viral infections research
